Arphra/Issuer/IQV

IQV

IQVIA Holdings Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$182.21

+0.61%LiveMay 29, 2026

AI Brief

Market cap

$30.41B

52w range

136.41 – 247.05

P / E

—

EPS

—

Volume

1.5M

Revenue · FY

$16.31B

+5.87% YoY

Explain this page

Arphra AIPlain-English read on IQVIA Holdings Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$22.68M

10 txns

Net flow

−$22.68M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$159.46

Change

+14.64%

Period high

$244.29

Period low

$139.10

Period start

$139.102025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+0.62%	+11.40%	+15.49%	+1.90%	-20.25%	-19.17%	+30.99%	-8.42%	-23.20%	+168.51%	+332.70%

Aftermarket

Live

Jun 01, 01:15 PM

Last trade

$181.00

316 sh

Bid

$180.00

1 sh

Ask

$183.88

3 sh

Spread

$3.880

Sector & industry today

Live

Sectors

Technology
+0.21%
Basic Materials
+0.15%
Financial Services
-0.43%
Industrials
-0.48%
Energy
-0.58%
Consumer Defensive
-0.79%
Consumer Cyclical
-0.85%
Real Estate
-0.98%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Medical - Diagnostics & Research
+1.67%
Software - Infrastructure
+6.80%
Coal
-6.27%
Information Technology Services
+6.00%
Medical - Healthcare Information Services
+5.23%
Other Precious Metals
+3.84%
Broadcasting
-3.48%
Silver
+2.89%
Renewable Utilities
-2.75%
Software - Application
+2.71%
Travel Lodging
-2.70%
Internet Content & Information
-2.61%

Fair value

Football field →

Weighted blend

$447.34

+145.51% vs spot

Recommendation

Strong Buy

14 of 16 methods

Method spread

9bull4bear

±5% threshold

Analyst PT consensus: $225.63 (+23.83%)

Total assets

$29.94B

Total debt

$16.17B

Cash & equiv

$1.98B

Operating CF

$2.65B

Free cash flow

$2.05B

Buybacks

-$1.24B

Analyst view

DB · price_targets + analyst_grades

Consensus target

$225.63

+23.83% upside

Low

$185.00

Median

$230.00

High

$250.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q4 Dec 2025	$4.36B	$514M	$2.99
Q3 Sep 2025	$4.1B	$331M	$1.93
Q2 Jun 2025	$4.02B	$266M	$1.54
Q1 Mar 2025	$3.83B	$249M	$1.40
Q4 Dec 2024	$3.96B	$437M	$2.42
Q3 Sep 2024	$3.9B	$285M	$1.55

Recent insiders

All →

Insider	Action	Shares	Value	Date
BOUSBIB ARI director, officer: See Remarks	Sell	36,564	$8.13M	Dec 18, 2025
BOUSBIB ARI director, officer: See Remarks	Sell	7,315	$1.6M	Oct 29, 2025
BOUSBIB ARI director, officer: See Remarks	Sell	3,973	$881.89K	Oct 29, 2025
BOUSBIB ARI director, officer: See Remarks	Sell	13,741	$3.01M	Oct 29, 2025
BOUSBIB ARI director, officer: See Remarks	Sell	26,128	$5.78M	Oct 29, 2025
BOUSBIB ARI director, officer: See Remarks	Sell	800	$174.06K	Oct 29, 2025

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$16.31B	$2.29B	$1.36B	$7.84	+8.34%
FY 2024	$15.41B	$2.2B	$1.37B	$7.49	+8.91%
FY 2023	$14.98B	$1.98B	$1.36B	$7.29	+9.06%
FY 2022	$14.41B	$1.8B	$1.09B	$5.72	+7.57%
FY 2021	$13.87B	$1.39B	$966M	$4.95	+6.96%